Journal profile · Biochemistry, Genetics and Molecular Biology-Genetics
Current Stem Cell Reports
ISSN 2198-7866 · Springer Nature · 4 issues per year
Current Stem Cell Reports: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.6 (journal website); hybrid open access; APC about USD 3,990; median 64 days to acceptance (15 articles, last 24 months); 10 articles in 2025; indexed in ESCI and Scopus.
Scope
Aims, scope and focus
Current Stem Cell Reports is published by Springer Nature and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pluripotent Stem Cells Research, Hematopoietic Stem Cell Transplantation and Mesenchymal stem cell research, together about 29.6% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The goal of this journal is to publish cutting-edge reviews on subjects pertinent to all aspects of stem cell research, therapy, ethics, commercialization, and policy. We aim to provide incisive, insightful, and balanced contributions from leading experts in each relevant domain that will be of immediate interest to a wide readership of clinicians, basic scientists, and translational investigators. We accomplish this aim by appointing major authorities to serve as Section Editors in key subject areas across the discipline. Section Editors select topics to be reviewed by leading experts who emphasize recent developments and highlight important papers published over the past year on their topics, in a crisp and readable format. We also provide commentaries from well-known figures in the field, and an Editorial Board of internationally diverse members suggests topics of special interest to their country/region and ensures that topics are current and include emerging research.
From the journal's Aims & Scope
Research area (LetPub): Biochemistry, Genetics and Molecular Biology-Genetics
Editor-in-chief Graça Almeida-PoradaPublisher website
Editorial board by country: none in mainland China; most named United States 24, France 2, Canada 2, United Kingdom 1, Germany 1 (34 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pluripotent Stem Cells ResearchBiochemistry, Genetics and Molecular Biology12.7%
- Hematopoietic Stem Cell TransplantationMedicine9.3%
- Mesenchymal stem cell researchMedicine7.6%
- Cancer Cells and MetastasisMedicine7.1%
- 3D Printing in Biomedical ResearchEngineering6.4%
- CRISPR and Genetic EngineeringBiochemistry, Genetics and Molecular Biology6.2%
- Tissue Engineering and Regenerative MedicineMedicine6%
- Biomedical Ethics and RegulationMedicine5.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Cell & Tissue Engineering | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 1.6Publisher website ·
- 5-year impact factor (publisher) 2025
- 2.1Publisher website ·
- CiteScore 2026-06
- 5.2LetPub ·
- SJR 2026-06
- 0.61LetPub ·
- SNIP 2026-06
- 0.58LetPub ·
- h-index
- 33OpenAlex ·
- i10-index
- 102OpenAlex ·
- 2-year mean citedness
- 2.6OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 58.62%LetPub ·
Volume
- Articles per year
- 10LetPub ·
- Downloads per year (publisher) 2025
- 105,800Publisher website ·
Articles by year OpenAlex count · 258 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 9 | 4 | 1 |
| 2025 | 10 | 7 | 29 |
| 2024 | 11 | 7 | 48 |
| 2023 | 8 | 5 | 41 |
| 2022 | 20 | 10 | 317 |
| 2021 | 18 | 8 | 145 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
64 daysMedian, submission to acceptance · P25–P75 40 days – 88 days
- Acceptance to online
- median 20 days (20 articles)
- Submission to online
- median 77 days
- Sample
- 15 articles with submission and acceptance dates (20 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 14 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 3,990 / EUR 3,090 / GBP 2,690 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare4 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Suggested reviewers
- Optional
Article types accepted2
- commentaryReview Articles and Invited Commentaries. Back to topLength not stated
- review articleReview Articles and Invited Commentaries. Back to topLength not stated
Policy excerpts from the journal's websiteAI use, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Current Stem Cell Reports, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer Nature
- Frequency
- 4 issues per year
- ISSN
- 2198-7866
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Current Stem Cell Reports
What CAS zone is Current Stem Cell Reports in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Stem Cell Reports is in Zone 4 of Medicine, and in Zone 4 of the minor category Cell & Tissue Engineering. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Stem Cell Reports?
The journal's website gives an impact factor of 1.6 (2025); this is the journal's own figure, as LetPub lists none for it; CiteScore 5.2, h-index 33.
How long does peer review take at Current Stem Cell Reports?
Based on the dates recorded on 15 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 64 days (interquartile range 40–88 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Current Stem Cell Reports?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Current Stem Cell Reports based?
Of the 34 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (24), France (2) and Canada (2). Counted from the institutions listed on the board page; for reference only.
Which databases index Current Stem Cell Reports?
According to LetPub and DOAJ records, Current Stem Cell Reports is indexed in ESCI and Scopus. The journal's website also lists Embase and CAS; that list has not been checked against each database.
Is Current Stem Cell Reports open access, and what is the APC?
Current Stem Cell Reports is a hybrid journal. For open-access publication: APC about USD 3,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .